Ijpsr Journal (2025)

19/07/2025

📢 Last Day to Register – Closes Today at 5:00 PM IST!

Join us for the 96th Society of Pharmaceutical Sciences and Research (SPSR) Webinar on the topic: 'Revolutionizing Eye Care: Nanoparticulate Systems for Enhanced Ocular Drug Delivery'

🗓 Date: Sunday, 20th July 2025

🕚 Time: 11:00 AM IST

📍 Platform: Live on Society of Pharmaceutical Sciences and Research (SPSR) YouTube Channel

🎙️ Esteemed Speaker: Dr. Himanshu Pandey, Director (CTE) & Deputy Registrar, Central University of Higher Tibetan Studies, Varanasi (UP), India.

🔴 Watch Live on Society of Pharmaceutical Sciences and Research (SPSR) YouTube Channel: https://youtube.com/live/C6_zYvKyNT8?feature=share

📝 Register Now (Closes at 5 PM IST today!): https://forms.gle/QJzsQo1XtTUTctew7

Not a Member Yet?

Become a part of Society of Pharmaceutical Sciences and Research (SPSR) and elevate your professional journey in pharmaceutical sciences.

📌 Learn more: https://spsrpharma.org

We look forward to your participation in this impactful academic event!

18/07/2025

🫀Cardiomyopathy refers to a group of diseases that impair the heart muscle’s ability to pump effectively. Among them, Takotsubo cardiomyopathy (TTC) — also known as “broken heart syndrome” — is a transient, stress-induced condition affecting the left ventricle.

But is it really just about the left side?

Recent evidence highlights the often-overlooked role of the right ventricle (RV) in TTC — and how its involvement can profoundly worsen outcomes.

🔍 Why read this article?

✅ Learn the true prevalence of RV involvement in TTC (up to 50%!)
✅ Understand its complex pathophysiology: catecholamines, microvascular dysfunction & more
✅ Discover how RV dysfunction impacts mortality, complications, and clinical course
✅ Explore diagnostic challenges and advances in imaging & biomarkers
✅ Gain insights into management strategies and future directions

Clinicians and researchers alike need to recognize that RV involvement is not rare — and it matters.

📌 Key takeaways:

🩸 RV involvement in TTC is more common than previously thought, and linked with poorer outcomes.
🩸Advanced imaging and biomarkers are improving detection and risk stratification.
🩸A tailored, patient-specific management approach is critical — especially in vulnerable populations.
🩸Ongoing research is vital to develop standardized criteria and targeted therapies.

In TTC, the right ventricle deserves equal attention as the left. Awareness, early recognition, and appropriate management can make a meaningful difference in patient care.

🚀 Read the full article here https://ijpsr.com/bft-article/right-ventricular-involvement-in-takotsubo-cardiomyopathy/?view=fulltext to deepen your understanding and stay at the forefront of cardiology practice.

➖ ➖ ➖ ➖ ➖ ➖➖ ➖ ➖➖ ➖ ➖➖ ➖ ➖➖ ➖ ➖➖ ➖ ➖➖ ➖ ➖➖➖ ➖ ➖

Become a Member of Society of Pharmaceutical Sciences and Research - SPSR - Elevate Your Professional Journey! For more details visit https://spsrpharma.org

17/07/2025

👁️ Revolutionizing Eye Care: Nanoparticulate Systems for Enhanced Ocular Drug Delivery

The unique anatomy and protective barriers of the eye pose significant challenges to effective drug delivery, often limiting therapeutic outcomes. 🧪

Nanoparticulate systems—such as nanoparticles, liposomes, and dendrimers—offer a groundbreaking solution by enabling 🎯 targeted, ⏳ sustained, and 💊 more efficient delivery of drugs to ocular tissues.

These innovative carriers improve 🔬 bioavailability, 📉 reduce dosing frequency, and 😊 enhance patient compliance, marking a 🌟 new era in the treatment of ocular diseases.

We are delighted to invite you to our upcoming 96th Society of Pharmaceutical Sciences and Research (SPSR) Webinar on: 🎯 Revolutionizing Eye Care: Nanoparticulate Systems for Enhanced Ocular Drug Delivery

This session will explore how innovative nanoparticulate systems—including nanoparticles, liposomes, and dendrimers—are transforming ocular drug delivery by overcoming traditional barriers, improving bioavailability, reducing dosing frequency, and enhancing patient outcomes.

🗓 Date: Sunday, 20th July 2025
🕚 Time: 11:00 AM IST
🎙️ Speaker: Dr. Himanshu Pandey, Director (CTE) & Deputy Registrar, Central University of Higher Tibetan Studies, Varanasi (UP), India.

🔴 Watch Live on Society of Pharmaceutical Sciences and Research (SPSR) YouTube Channel: https://youtube.com/live/C6_zYvKyNT8?feature=share

📝 Register Here: https://forms.gle/QJzsQo1XtTUTctew7

📌 Last date for registration: 19th July 2025, 5:00 PM IST

🔍 Reasons to attend:

✅ Learn about cutting-edge nanotechnology applications in ophthalmology
✅ Understand mechanisms of targeted and sustained drug delivery
✅ Gain insights into future trends and research opportunities in ocular therapeutics

We look forward to your participation in this insightful discussion on the future of eye care.

➖ ➖ ➖ ➖ ➖ ➖➖ ➖ ➖➖ ➖ ➖➖ ➖ ➖➖ ➖ ➖➖ ➖ ➖➖ ➖ ➖➖➖ ➖ ➖

Become a Member of Society of Pharmaceutical Sciences and Research (SPSR) - Elevate Your Professional Journey! For more details visit https://spsrpharma.org

14/07/2025

Unmasking Cardiac Sarcoidosis ❤️ : Advancements in Diagnosis & Treatment

Cardiac sarcoidosis (CS) ❤️ is a rare but serious manifestation of systemic sarcoidosis — an inflammatory disease marked by non-caseating granulomas that infiltrate the heart. Its variable symptoms and potential for life-threatening complications make timely recognition critical.

🩺 Symptoms of Cardiac Sarcoidosis ❤️ to watch for:

⚡ Palpitations & arrhythmias
🌀 Dizziness or fainting (syncope)
❤️ Chest pain mimicking angina
🫁 Shortness of breath & fatigue
🩺 Heart block or sudden cardiac arrest
🦵 Signs of heart failure, like edema

✅ What you’ll learn 📚

This article highlights recent breakthroughs in the management of CS ❤️— from advanced imaging (cardiac MRI, PET-CT) and biopsy techniques to evolving therapies like targeted immunosuppressants and life-saving devices such as ICDs.

It also underscores the power ⚡ of interdisciplinary collaboration in improving patient outcomes.

✅ Heightened clinical awareness 🔈 and early, accurate diagnosis are key to mitigating the devastating consequences of cardiac sarcoidosis ❤️. Stay informed about ongoing research and emerging best practices to optimize care.

🔗 Read the full article here https://ijpsr.com/bft-article/cardiac-sarcoidosis-advancements-in-diagnostic-techniques-and-management/?view=fulltext to stay ahead in managing this challenging condition.

✨ "Spot the silent threat. Save lives. Lead with knowledge." ✨

➖ ➖ ➖ ➖ ➖ ➖➖ ➖ ➖➖ ➖ ➖➖ ➖ ➖➖ ➖ ➖➖ ➖ ➖➖ ➖ ➖

Become a Member of Society of Pharmaceutical Sciences and Research - SPSR - Elevate Your Professional Journey! For more details visit https://spsrpharma.org

12/07/2025

🎯 Targeted Nanoconstructs: Transforming Autoimmune Disease Treatment 🎯

Autoimmune diseases pose a unique challenge, as the body’s own immune system turns against healthy tissues, and conventional therapies often come with widespread side effects.

Targeted 🎯 nanoconstructs—specially designed nanoscale drug delivery systems—are changing the game. By transporting therapeutic agents directly to the diseased sites, they reduce systemic toxicity and improve treatment outcomes.

These innovative platforms mark a significant step forward in the journey toward precision medicine for autoimmune disorders.

🤝 Join us for the 95th Society of Pharmaceutical Sciences and Research (SPSR) Webinar!

Targeted Nanoconstructs: A New Era in Autoimmune Disease Treatment

We are pleased to invite you to the 95th Society of Pharmaceutical Sciences and Research (SPSR) Webinar, where you’ll learn how cutting-edge nanotechnology is transforming the treatment landscape for autoimmune diseases.

🗓️ Date: Sunday, 13th July 2025
🕚 Time: 11:00 AM IST
🎤 Speaker: Dr. Manju Rawat Singh
Professor, University Institute of Pharmacy, Pt. Ravishankar Shukla University, Raipur (C.G.), India.

📺 Live on Society of Pharmaceutical Sciences and Research (SPSR) YouTube Channel. You can use this link to visit the Society of Pharmaceutical Sciences and Research (SPSR) YouTube Channel: https://youtube.com/live/rRNO5ay9IvY?feature=share

📝 Register by 12th July 2025, 5 PM IST. Please click on the following link to reach the registration form: https://forms.gle/JCDPwJwCEXqMXW3T9

🔴 What makes this webinar valuable❓

✅ Learn how nanoconstructs enable site-specific, precision therapy in autoimmune diseases.
✅ Stay updated on emerging research and innovations in nanomedicine.
✅ Hear from a leading expert in pharmaceutical sciences and nanotechnology.
✅ Enhance your knowledge to drive better research and patient outcomes.
✅ Network with peers passionate about advancing healthcare and science.

✔️ Don’t miss this opportunity to explore how cutting-edge nanotechnology is shaping the future of autoimmune disease treatment. Join us to stay ahead with insights that can inspire innovation and improve patient care.

Become a Member of Society of Pharmaceutical Sciences and Research - SPSR - Elevate Your Professional Journey! For more details visit https://spsrpharma.org

11/07/2025

🔔 FDA July Approval Alert: Lynozyfic™ (linvoseltamab‑gcpt) 💊
🎯 "Targeting Hope, Empowering T‑Cells, Fighting Myeloma 🎗️

FDA has approved Lynozyfic™ (linvoseltamab‑gcpt) 💊 on July 2, 2025, offering a novel treatment option for relapsed or refractory multiple myeloma 🎗️(RRMM) — a major milestone in oncology care.

Lynozyfic 💊 is a bispecific B‑cell maturation antigen (BCMA)–directed CD3 T‑cell 🧬 engager that brings a targeted immunotherapy approach to patients with heavily pretreated disease.

🔍 Key Takeaways:

✅ Indication: For adult patients with relapsed or refractory multiple myeloma after ≥4 prior therapies (including a PI, IMiD, and anti‑CD38 monoclonal antibody).

🧬 Mechanism of Action: Lynozyfic 💊 binds to BCMA on myeloma cells and CD3 on T‑cells, redirecting T‑cells to attack and kill malignant plasma cells.

🔬 Therapeutic Innovation: First of its kind in its class, addressing an unmet need in advanced stages of this incurable blood cancer.

👩‍⚕️ Impact: Expands the treatment landscape for a challenging patient population with limited options.

The approval of Lynozyfic 💊 marks a step forward in the fight against multiple myeloma🎗️, giving new hope to patients and clinicians striving for better outcomes.

Become a Member of Society of Pharmaceutical Sciences and Research - SPSR (SPSR) - Elevate Your Professional Journey! For more details visit https://spsrpharma.org

10/07/2025

⏰ Treat the right disease, with the right drug, at the right time!

🏃‍♂️‍➡️ Our bodies run on an incredible internal clock 🕒 — the circadian rhythm, a 24-hour biological cycle that governs countless metabolic, physiological, and behavioral processes. Disruptions to these rhythms can influence disease patterns and impact the effectiveness of treatments.

🚪Enter Chronotherapy — a cutting-edge approach 🩺 in drug delivery that aligns medication timing with the body’s natural rhythms to enhance therapeutic outcomes and minimize side effects.

Here’s why you should explore more about this fascinating concept:

🔷 What are Circadian Rhythms?

🅾️ Internal biological clocks ⏳ regulating sleep 😴 , hormone levels ⬆️ , blood pressure 💓 , and metabolism.
🅾️ Synchronized with environmental cues like light 🌞 and dark 🌙.

🔷 Why Chronotherapeutics Matter:

✅ Ensures drug action coincides with 🩹 disease peak symptoms.
✅ Improves patient 👥 compliance and convenience.
✅ Reduces ⬇️ dosing frequency and toxicity.
✅ Makes therapy more effective and personalized.

🔷 🩺 Diseases Benefiting from Chronotherapy:

❇️ Hypertension ❤️ & myocardial infarction
❇️ Bronchial asthma 🌬️ & arthritis
❇️ Peptic & duodenal ulcers
❇️ Diabetes🩸& neurological disorders
❇️ Cancer🎗️& hypercholesterolemia

📚 This article delves into the 🔍 science of chronobiology, explaining how biological rhythms shape our health and disease patterns. It explores 💊 chronopharmacology and ⏱️ chronokinetics of drugs, shedding light on how drug action and metabolism vary over time.

Finally, it highlights 🩺 applications of chronotherapy in modern medicine, showcasing how timing-based treatment can improve outcomes across various diseases.

If you’re interested in how synchronizing therapy with our body’s natural rhythms could revolutionize disease management, this article is for you.

Read complete article here: https://ijpsr.com/bft-article/time-optimized-drug-delivery-the-role-of-chronotherapy-in-modern-therapeutics/?view=fulltext

Chronotherapeutics is not just about what drug to take — but when to take it. Adopting this ⏰ patient-centric, rhythm-conscious approach promises safer, smarter, and more effective therapies in the future.

Become a Member of Society of Pharmaceutical Sciences and Research (SPSR) - Elevate Your Professional Journey! For more details visit https://spsrpharma.org

Ijpsr Journal

19/07/2025

18/07/2025

17/07/2025

14/07/2025

12/07/2025

11/07/2025

10/07/2025

Address

Telephone

Website

Alerts

Contact The Business

Shortcuts

Share